Lactulose detoxifies in vitro short-chain fatty acid production in colonic contents induced by blood: Implications for hepatic coma

Abstract

Short-chain (C2–C6) fatty acids constitute the major anions of colonic contents. Acetate is nontoxic in contrast to C(3)4–C6 fatty acids, which induce coma in animals and have been reported to be of importance in the development of hepatic coma in humans. An in vitro fecal incubation system was used to demonstrate how blood, hemoglobin, albumin, lactulose, galactose, fructose, and glucose influence short-chain fatty acid production in the colon. Blood, hemoglobin, and albumin caused increased production of all C2–C6 fatty acids, with the most pronounced increase (fourfold) in C4–C6 fatty acids. Lactulose was converted to acetate only, as were its monosaccharide components, d-galactose and d-fructose. In assays incubated with blood, the production of C4–C6 fatty acids was completely inhibited by lactulose, d-galactose, d-fructose, and d-glucose, respectively, whereas the production of acetate was increased. Lactulose thus “detoxified” the profile of short-chain fatty acids produced in the presence of blood and proteins, indicating that colonic fermentative bacteria prefer lactulose to blood when both substrates are available. The effect of lactulose in the treatment of hepatic coma caused by episodes of gastrointestinal bleeding may therefore be due to a shift in bacterial metabolism from blood or proteins, or both, to lactulose in the colon, resulting in a simultaneous reduction in toxic nitrogenous and organic acid products.